Sino Biopharmaceutical Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
7,694.00
5,850.00
6,558.00
6,897.00
5,956.00
5,636.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
2,846.00
108.00
-475.00
-227.00
-408.00
293.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
12,355.00
9,057.00
7,307.00
8,511.00
11,635.00
6,312.00
Cash Flow from Investing Activities
-16,019.00
-3,976.00
-1,972.00
-6,328.00
-8,247.00
-9,365.00
Cash Flow from Financing Activities
4,786.00
-6,609.00
-6,705.00
-3,337.00
-3,839.00
2,730.00
Net Cash Inflow / Outflow
1,250.00
-1,380.00
-1,270.00
-1,098.00
-1,234.00
-7.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
128.00
146.00
100.00
55.00
-783.00
314.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sino Biopharmaceutical Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
7694.44604396713
1014.80153226561
6,680.00
658.22%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
2846.32941742168
8616.04146868747
-5,770.00
-66.96%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
12355.1201582567
11084.8211876695
1,271.00
11.46%
Cash Flow from Investing Activities
-16019.0619841578
-7497.1289464026
-8,522.00
-113.67%
Cash Flow from Financing Activities
4786.74995613634
5231.42514406506
-445.00
-8.50%
Net Cash Inflow / Outflow
1250.85888914012
8693.76166700356
-7,443.00
-85.61%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
128.050758904901
-125.355718328345
253.00
202.15%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 36.40% vs 23.95% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
12,355.12
9,057.94
36.40%






